Department of Urological Surgery, The Second Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Centre for Translational Medicine, The Second Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
BMC Surg. 2023 Nov 21;23(1):356. doi: 10.1186/s12893-023-02266-2.
The large amount of intraoperative bleeding and the high incidence of postoperative hematuria are still common factors affecting the prostate surgery treatment effect. Our research aimed to observe the effect of prostatic enucleation using 1,470 nm semiconductor laser on the amount of bleeding in patients with different sizes of prostate hyperplasia.
According to the size of the prostate, forty eligible patients with benign prostatic hyperplasia (BPH) were enrolled and divided into low and high volume group in this study. Hemoglobin decline, urinating condition, complications and erectile function were collected and compared before and after surgery.
Our data showed that hemoglobin decline was (10.0 ± 6.2) g/L and (12.1 ± 7.8) g/L, respectively for two group after surgery (P = 0.363). Urination was significantly improved following surgery in both groups of patients (P < 0.05), and no permanent urinary incontinence and sexual dysfunction and so no serious complications occurred.
The above results suggested that prostatic enucleation using 1,470 nm semiconductor laser can be safe and effective for prostatic hyperplasia, and this surgery produced no significant effect on the amount of bleeding in whatever size of the prostate.
术中出血量较大和术后血尿发生率高仍然是影响前列腺手术治疗效果的常见因素。我们的研究旨在观察 1470nm 半导体激光前列腺剜除术对不同大小前列腺增生患者出血量的影响。
根据前列腺体积大小，将 40 例符合条件的良性前列腺增生（BPH）患者纳入本研究，并分为低体积组和高体积组。收集并比较两组患者手术前后的血红蛋白下降、排尿情况、并发症和勃起功能。
我们的数据显示，两组患者术后的血红蛋白下降量分别为（10.0±6.2）g/L 和（12.1±7.8）g/L（P=0.363）。两组患者术后排尿均明显改善（P<0.05），且均未发生永久性尿失禁和性功能障碍等严重并发症。
上述结果表明，1470nm 半导体激光前列腺剜除术治疗前列腺增生安全有效，且对任何大小的前列腺出血量均无显著影响。
